Related references
Note: Only part of the references are listed.Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis
Maria Giovanna Danieli et al.
AUTOIMMUNITY REVIEWS (2009)
Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study
F. Falcini et al.
LUPUS (2009)
Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?
Luca Iaccarino et al.
AUTOIMMUNITY REVIEWS (2007)
Mycophenolate mofetil in dermatomyositis: Is it safe?
J Rowin et al.
NEUROLOGY (2006)
Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis
JC Edge et al.
ARCHIVES OF DERMATOLOGY (2006)
Advances in the treatment of juvenile dermatomyositis
Elizabeth Stringer et al.
CURRENT OPINION IN RHEUMATOLOGY (2006)
Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis
E Dauden et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
DA Isenberg et al.
RHEUMATOLOGY (2004)
US incidence of juvenile dermatomyositis, 1995-1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry
EP Mendez et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Share Paper
